Nuzyra 150 MG tablet UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4BDQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,830
Award facts
- Contract value 100% obligated
- $19,829.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $19,829.84 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for NUZYRA 150 MG tablets (nemonoxacin oral antibiotic), firm fixed price, with ultimate completion by May 13, 2026.
Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to Defense Health Agency and military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4BDQ?
SPE2DR26F4BDQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 22, 2026.
How much is contract SPE2DR26F4BDQ worth?
The government has obligated $19,830 on SPE2DR26F4BDQ.
Is contract SPE2DR26F4BDQ an order under another contract?
Yes. SPE2DR26F4BDQ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F4BDQ competed?
The extent of competition for SPE2DR26F4BDQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award